We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Development and manufacturing deal leverages Lonza’s network of process development and GMP-manufacturing facilities across Europe and the US for Abelacimab.